BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

755 related articles for article (PubMed ID: 19335948)

  • 1. Evidence of protective effect of BCG vaccination in persons at low risk of tuberculosis in Nordic countries.
    Brantsaeter AB; Romanus V; Andersen PH; Heldal E
    Int J Tuberc Lung Dis; 2009 Apr; 13(4):440-5. PubMed ID: 19335948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tuberculosis control in Scandinavia].
    Romanus V; Tala E; Blöndal T; Heldal E; Poulsen S
    Nord Med; 1995; 110(2):45-7. PubMed ID: 7854909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cost-effectiveness analysis of universal versus selective immunization with Mycobacterium bovis bacille Calmette-Guérin in Finland.
    Hersh AL; Tala-Heikkilä M; Tala E; Tosteson AN; Fordham von Reyn C
    Int J Tuberc Lung Dis; 2003 Jan; 7(1):22-9. PubMed ID: 12701831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.
    Hesseling AC; Marais BJ; Gie RP; Schaaf HS; Fine PE; Godfrey-Faussett P; Beyers N
    Vaccine; 2007 Jan; 25(1):14-8. PubMed ID: 16959383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCG in Finland: changing from a universal to a selected programme.
    Salo EP
    Euro Surveill; 2006; 11(3):18-20. PubMed ID: 16567879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mass vaccination against tuberculosis--is it necessary in Norway?].
    Eskild A
    Tidsskr Nor Laegeforen; 1994 Jun; 114(16):1840-4. PubMed ID: 8079303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of changing BCG coverage on tuberculosis incidence in Swedish-born children between 1969 and 1989.
    Romanus V; Svensson A; Hallander HO
    Tuber Lung Dis; 1992 Jun; 73(3):150-61. PubMed ID: 1421348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective BCG vaccination in a country with low incidence of tuberculosis.
    Romanus V
    Euro Surveill; 2006; 11(3):14-7. PubMed ID: 16567880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal BCG vaccination in Ireland: evidence of its efficacy in the prevention of childhood tuberculosis.
    Kelly P; McKeown D; Clancy L
    Eur Respir J; 1997 Mar; 10(3):619-23. PubMed ID: 9072995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of mass BCG vaccination at birth on the incidence of tuberculosis among Jewish children in Israel.
    Zilber N; Simchen E; Wartski S; Marcus JH; Shakya GR
    Isr J Med Sci; 1984 Dec; 20(12):1150-7. PubMed ID: 6519946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted BCG vaccination against severe tuberculosis in low-prevalence settings: epidemiologic and economic assessment.
    Altes HK; Dijkstra F; Lugnèr A; Cobelens F; Wallinga J
    Epidemiology; 2009 Jul; 20(4):562-8. PubMed ID: 19295437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis.
    Araujo Z; de Waard JH; de Larrea CF; Borges R; Convit J
    Vaccine; 2008 Oct; 26(44):5575-81. PubMed ID: 18723065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCG coverage and the annual risk of tuberculosis infection over a 14-year period in the Philippines assessed from the Nationwide Prevalence Surveys.
    Tupasi TE; Radhakrishna S; Pascual ML; Quelapio MI; Villa ML; Co VM; Sarol J; Mangubat N; Reyes AC; Sarmiento A; Solon M; Solon F; Burton L; Lofranco VS; Rostrata MP; Mantala MJ
    Int J Tuberc Lung Dis; 2000 Mar; 4(3):216-22. PubMed ID: 10751066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of some hypotheses related to the Chingelput bacille Calmette-Guérin trial.
    Smith D; Wiegeshaus E; Balasubramanian V
    Clin Infect Dis; 2000 Sep; 31 Suppl 3():S77-80. PubMed ID: 11010828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paediatric tuberculosis during universal and selective
    Kontturi A; Kekomäki S; Soini H; Ollgren J; Salo E
    Euro Surveill; 2021 Mar; 26(11):. PubMed ID: 33739257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculin reactivity in adults after 50 years of universal bacille Calmette-Guerin vaccination in Taiwan.
    Yeh YP; Luh DL; Chang SH; Suo J; Chang HJ; Chen TH
    Trans R Soc Trop Med Hyg; 2005 Jul; 99(7):509-16. PubMed ID: 15910894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology of childhood tuberculosis in the Basque Autonomous Community 1980-89. Efficacy of BCG vaccination].
    Errezola Saizar M; Arístegui Fernández J; Gutiérrez Villamayor C; Pérez Díaz L; Zubillaga Huici P
    An Esp Pediatr; 1992 Mar; 36(3):177-80. PubMed ID: 1580424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the impact of different BCG vaccination strategies on severe childhood TB in low-intermediate prevalence settings.
    Manissero D; Lopalco PL; Levy-Bruhl D; Ciofi Degli Atti ML; Giesecke J
    Vaccine; 2008 Apr; 26(18):2253-9. PubMed ID: 18400344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping the global use of different BCG vaccine strains.
    Ritz N; Curtis N
    Tuberculosis (Edinb); 2009 Jul; 89(4):248-51. PubMed ID: 19540166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of effectiveness of BCG vaccination against childhood tuberculosis].
    Takamatsu I; Kameda M; Inoue T; Toyoshima K
    Kekkaku; 1995 Sep; 70(9):561-6. PubMed ID: 8523863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.